Table 1 |
|||
|
Clinical and laboratory characteristics in patients with rheumatoid arthritis (RA) and osteoarthritis (OA), and healthy control (HC) subjects. |
|||
|
Parameter |
RA (n = 54) |
OA (n = 20) |
HC (n = 60) |
|
|
|||
|
Age (y) |
48.2 (17-65) |
61 (57-82) |
43.4 (24-64) |
|
Sex (female/male) |
34/6 |
24/4 |
20/5 |
|
Median age at onset (y) |
40 (13-63) |
- |
- |
|
Median disease duration (m) |
36 (3-444) |
- |
- |
|
Number of tender joints |
6.50 (0-28) |
- |
- |
|
Number of swollen joints |
1.50 (0-28) |
- |
- |
|
ESR (mm/h) |
37.5 (10-125) |
- |
- |
|
CRP (mg/l) |
10.32 (2.97-84.5) |
- |
- |
|
RF (U/I) |
76.4 (10.3-954) |
- |
- |
|
DAS28-ESR |
4.58 ± 2.08 |
- |
- |
|
BMI (kg/m2) |
22.45 (16.65-28.55) |
- |
22.91 (17.33-26.17) |
|
Total cholesterol (mmol/l) |
4.41 (2.55-6.16) |
- |
5.19 (3.9-7.1) |
|
Triglycerides (mmol/l) |
1.44 (0.49-2.15) |
- |
1.46 (0.84-3.11) |
|
|
|||
|
The values shown represent the median and the ranges. BMI, body mass index; CRP C-reactive protein; DAS28, 28-joint Disease Activity Score; ESR, erythrocyte sedimentation rate; RF, rheumatoid factor. |
|||
|
Wang et al. Arthritis Research & Therapy 2012 14:R228 doi:10.1186/ar4067 |
|||
